Pharma-bio Serv (PBSV) Gross Profit Margin starting from the third quarter 2026 to third quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Pharma-Bio Serv, Inc.  (OTC: PBSV)
    Sector • Services    Industry • Consulting Services
   Industry • Consulting Services
   Sector • Services


Pharma-bio Serv's Gross Profit Margin by quarter

Trends, Rankings, Statistics



PBSV Gross Profit Margin (Jul 31 2026)
Q3
(Apr 30 2026)
Q2
(Jan 31 2026)
Q1
(Oct 31 2025)
Q4
(Jul 31 2025)
Q3
Y / Y Revenue Change 19 %
Seq. Revenue Change -13.57 %
Revenue In Millions $2.34
Gross Profit Margin 29.61 %
Gross Profit Margin Total Ranking # 2694
Gross Profit In Millions $0.69
Y / Y Gross Profit Change 20.45 %
Seq. Gross Profit Change -23.31 %


Commenting Third Quarter 2026 Gross Profit Margin
Pharma-Bio Serv, Inc. experienced contraction in Gross Profit by -23.31 % to $2 millions and Revenue by -13.57 %, while Gross Profit Margin fell to 29.61 %, below company*s average Gross Profit Margin.


Observing third quarter 2026 results within Consulting Services industry Pharma-Bio Serv, Inc. has achieved highest Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from 2363 to 2694.
Learn about Gross Margin
PBSV's Gross Profit Margin third quarter 2026 Company Ranking
Within: No.
Consulting Services Industry #
Services Sector #
Overall # 0

Gross Profit Margin Statistics
High Average Low
50.14 % 30.09 % 16.78 %
(Oct 31 2018)   (Oct 31 2017)




Other Gross Profit Margin Profitability Ratios
PBSV's Cumulative Gross Profit Margin
Consulting Services Industry Gross Profit Margin Trends and Statistics
Services Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
PBSV's Gross Profit Margin Profitability versus Consulting Services Industry, Services Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for PBSV's Competitors
Gross Profit Margin Profit Margin for Pharma-bio Serv's Suppliers
Gross Profit Margin Profit Margin for PBSV's Customers

You may also want to know
PBSV's Annual Growth Rates PBSV's Profitability Ratios PBSV's Asset Turnover Ratio PBSV's Dividend Growth
PBSV's Roe PBSV's Valuation Ratios PBSV's Financial Strength Ratios PBSV's Gross Profit Growth
PBSV's Roa PBSV's Inventory Turnover Ratio PBSV's Growth Rates PBSV's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jul 31 2026, within Consulting Services Industry Gross Profit MarginJul 31 2026 MRQ Gross ProfitJul 31 2026 MRQ Revenue
Access Newswire Inc   73.19 %$ 4.112  Millions$ 5.618  Millions
Greenpro Capital Corp   62.22 %$ 0.188  Millions$ 0.302  Millions
Bowman Consulting Group Ltd   53.20 %$ 77.740  Millions$ 146.125  Millions
Booz Allen Hamilton Holding Corporation  52.29 %$ 1,464.000  Millions$ 2,800.000  Millions
Information Services Group Inc   48.82 %$ 31.969  Millions$ 65.488  Millions
1847 Holdings Llc  45.42 %$ 0.712  Millions$ 1.567  Millions
Onterris Inc   44.07 %$ 82.260  Millions$ 186.661  Millions
Hackett Group Inc   39.97 %$ 27.710  Millions$ 69.328  Millions
Ryvyl Inc   37.41 %$ 0.871  Millions$ 2.328  Millions
Icf International Inc   37.23 %$ 176.639  Millions$ 474.495  Millions
Genpact Limited  36.50 %$ 490.338  Millions$ 1,343.438  Millions
Castellum Inc   34.04 %$ 4.719  Millions$ 13.865  Millions
Fti Consulting Inc  31.84 %$ 316.273  Millions$ 993.464  Millions
Pharma-Bio Serv, Inc.  29.61 %$ 0.692  Millions$ 2.336  Millions
Aeries Technology Inc   29.10 %$ 6.379  Millions$ 21.918  Millions
Mastech Digital Inc   28.95 %$ 11.999  Millions$ 41.447  Millions
Brilliant Acquisition Corp  25.35 %$ 1.013  Millions$ 3.996  Millions
Ciso Global Inc   24.57 %$ 1.423  Millions$ 5.791  Millions
Public Policy Holding Company Inc   21.77 %$ 11.351  Millions$ 52.143  Millions
Astrana Health Inc   9.10 %$ 88.472  Millions$ 972.520  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.